Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 06 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.

This report studies the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics that contribute to its increasing demand across many markets.

The global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Growth in the ADHD therapeutics market is mainly driven by granular impact of changing lifestyles and value systems impacting quality of births, increasing use of additives and preservations in children’s diet, rising prevalence of ADHD among children in the 4–17 year age group, increasing adoption of diagnostic guidelines (statistical manual of mental disorders) with low threshold for diagnosis of ADHD in other regions such as Europe and Latin America. Moreover, increasing awareness regarding ADHD among physicians and patients, and opinion-based diagnosis of ADHD owing to lack of standard diagnostic tests is expected to boost revenue growth of the global ADHD therapeutics market in the near future. However, existence of comorbid conditions in children leads to underdiagnoses of ADHD and less availability of non-stimulants ADHD drugs in various geographies. These are factors expected to restrain growth of the market over the forecast period.

Highlights and key features of the study
Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics total market, 2018-2029, (USD Million)
Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics total market, key domestic companies and share, (USD Million)
Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly and Company, Novartis, Takeda, Pfizer, GlaxoSmithKline, Mallinckrodt Pharmaceuticals, Hisamitsu Pharmaceutical, Impax Laboratories and Johnson ＆Johnson, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation by Type
    Stimulants
    Non-Stimulants

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Segmentation by Application
    Specialty Clinics
    Hospital Pharmacies
    Retail Pharmacies
    E-Commerce

Companies Profiled:
    Eli Lilly and Company
    Novartis
    Takeda
    Pfizer
    GlaxoSmithKline
    Mallinckrodt Pharmaceuticals
    Hisamitsu Pharmaceutical
    Impax Laboratories
    Johnson ＆Johnson
    UCB
    Purdue Parma

Key Questions Answered
1. How big is the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market?
2. What is the demand of the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market?
3. What is the year over year growth of the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market?
4. What is the total value of the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market?
5. Who are the major players in the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Introduction
    1.2 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Total Market by Region (by Headquarter Location)
        1.3.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
        1.3.3 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
        1.3.4 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
        1.3.5 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
        1.3.6 South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
        1.3.7 ASEAN Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
        1.3.8 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.2 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value by Region
        2.2.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value by Region (2018-2023)
        2.2.2 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.4 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.5 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.6 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.7 South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.8 ASEAN Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)
    2.9 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029)

3 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies Competitive Analysis
    3.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics in 2022
    3.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Company Evaluation Quadrant
    3.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Overall Company Footprint Analysis
        3.4.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Region Footprint
        3.4.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Company Product Type Footprint
        3.4.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Comparison
        4.2.1 United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies and Market Share, 2018-2023
        4.3.1 United States Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, (2018-2023)
    4.4 China Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Market Share, 2018-2023
        4.4.1 China Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, (2018-2023)
    4.5 Rest of World Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Stimulants
        5.2.2 Non-Stimulants
    5.3 Market Segment by Type
        5.3.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2018-2023)
        5.3.2 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2024-2029)
        5.3.3 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Specialty Clinics
        6.2.2 Hospital Pharmacies
        6.2.3 Retail Pharmacies
        6.2.4 E-Commerce
        6.2.5 E-Commerce
    6.3 Market Segment by Application
        6.3.1 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2018-2023)
        6.3.2 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2024-2029)
        6.3.3 World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Eli Lilly and Company
        7.1.1 Eli Lilly and Company Details
        7.1.2 Eli Lilly and Company Major Business
        7.1.3 Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.1.4 Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Eli Lilly and Company Recent Developments/Updates
        7.1.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.2.4 Novartis Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Takeda
        7.3.1 Takeda Details
        7.3.2 Takeda Major Business
        7.3.3 Takeda Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.3.4 Takeda Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Takeda Recent Developments/Updates
        7.3.6 Takeda Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.4.4 Pfizer Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Details
        7.5.2 GlaxoSmithKline Major Business
        7.5.3 GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.5.4 GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 GlaxoSmithKline Recent Developments/Updates
        7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.6 Mallinckrodt Pharmaceuticals
        7.6.1 Mallinckrodt Pharmaceuticals Details
        7.6.2 Mallinckrodt Pharmaceuticals Major Business
        7.6.3 Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.6.4 Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
        7.6.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Hisamitsu Pharmaceutical
        7.7.1 Hisamitsu Pharmaceutical Details
        7.7.2 Hisamitsu Pharmaceutical Major Business
        7.7.3 Hisamitsu Pharmaceutical Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.7.4 Hisamitsu Pharmaceutical Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Hisamitsu Pharmaceutical Recent Developments/Updates
        7.7.6 Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
    7.8 Impax Laboratories
        7.8.1 Impax Laboratories Details
        7.8.2 Impax Laboratories Major Business
        7.8.3 Impax Laboratories Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.8.4 Impax Laboratories Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Impax Laboratories Recent Developments/Updates
        7.8.6 Impax Laboratories Competitive Strengths & Weaknesses
    7.9 Johnson ＆Johnson
        7.9.1 Johnson ＆Johnson Details
        7.9.2 Johnson ＆Johnson Major Business
        7.9.3 Johnson ＆Johnson Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.9.4 Johnson ＆Johnson Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Johnson ＆Johnson Recent Developments/Updates
        7.9.6 Johnson ＆Johnson Competitive Strengths & Weaknesses
    7.10 UCB
        7.10.1 UCB Details
        7.10.2 UCB Major Business
        7.10.3 UCB Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.10.4 UCB Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 UCB Recent Developments/Updates
        7.10.6 UCB Competitive Strengths & Weaknesses
    7.11 Purdue Parma
        7.11.1 Purdue Parma Details
        7.11.2 Purdue Parma Major Business
        7.11.3 Purdue Parma Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
        7.11.4 Purdue Parma Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Purdue Parma Recent Developments/Updates
        7.11.6 Purdue Parma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry Chain
    8.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Upstream Analysis
    8.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Midstream Analysis
    8.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Players in 2022
    Table 12. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Company Evaluation Quadrant
    Table 14. Head Office of Key Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Player
    Table 15. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Company Product Type Footprint
    Table 16. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Company Product Application Footprint
    Table 17. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Mergers & Acquisitions Activity
    Table 18. United States VS China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share (2018-2023)
    Table 23. China Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share (2018-2023)
    Table 29. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2024-2029) & (USD Million)
    Table 35. Eli Lilly and Company Basic Information, Area Served and Competitors
    Table 36. Eli Lilly and Company Major Business
    Table 37. Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 38. Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Eli Lilly and Company Recent Developments/Updates
    Table 40. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 44. Novartis Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Takeda Basic Information, Area Served and Competitors
    Table 48. Takeda Major Business
    Table 49. Takeda Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 50. Takeda Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Takeda Recent Developments/Updates
    Table 52. Takeda Competitive Strengths & Weaknesses
    Table 53. Pfizer Basic Information, Area Served and Competitors
    Table 54. Pfizer Major Business
    Table 55. Pfizer Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 56. Pfizer Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Pfizer Recent Developments/Updates
    Table 58. Pfizer Competitive Strengths & Weaknesses
    Table 59. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 60. GlaxoSmithKline Major Business
    Table 61. GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 62. GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. GlaxoSmithKline Recent Developments/Updates
    Table 64. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 65. Mallinckrodt Pharmaceuticals Basic Information, Area Served and Competitors
    Table 66. Mallinckrodt Pharmaceuticals Major Business
    Table 67. Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 68. Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Mallinckrodt Pharmaceuticals Recent Developments/Updates
    Table 70. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
    Table 71. Hisamitsu Pharmaceutical Basic Information, Area Served and Competitors
    Table 72. Hisamitsu Pharmaceutical Major Business
    Table 73. Hisamitsu Pharmaceutical Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 74. Hisamitsu Pharmaceutical Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Hisamitsu Pharmaceutical Recent Developments/Updates
    Table 76. Hisamitsu Pharmaceutical Competitive Strengths & Weaknesses
    Table 77. Impax Laboratories Basic Information, Area Served and Competitors
    Table 78. Impax Laboratories Major Business
    Table 79. Impax Laboratories Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 80. Impax Laboratories Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Impax Laboratories Recent Developments/Updates
    Table 82. Impax Laboratories Competitive Strengths & Weaknesses
    Table 83. Johnson ＆Johnson Basic Information, Area Served and Competitors
    Table 84. Johnson ＆Johnson Major Business
    Table 85. Johnson ＆Johnson Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 86. Johnson ＆Johnson Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Johnson ＆Johnson Recent Developments/Updates
    Table 88. Johnson ＆Johnson Competitive Strengths & Weaknesses
    Table 89. UCB Basic Information, Area Served and Competitors
    Table 90. UCB Major Business
    Table 91. UCB Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 92. UCB Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. UCB Recent Developments/Updates
    Table 94. Purdue Parma Basic Information, Area Served and Competitors
    Table 95. Purdue Parma Major Business
    Table 96. Purdue Parma Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Services
    Table 97. Purdue Parma Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Upstream (Raw Materials)
    Table 99. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Typical Customers
List of Figure
    Figure 1. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Picture
    Figure 2. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 13. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Markets in 2022
    Figure 27. United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type in 2022
    Figure 31. Stimulants
    Figure 32. Non-Stimulants
    Figure 33. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Type (2018-2029)
    Figure 34. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Market Share by Application in 2022
    Figure 36. Specialty Clinics
    Figure 37. Hospital Pharmacies
    Figure 38. Retail Pharmacies
    Figure 39. E-Commerce
    Figure 40. Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 03 Jan 2023

date Medical Care

ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.

Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Medical Care

Attention-deficit/hyperactivity disorder (ADHD) is a disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development.

Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Supply, Demand and Key Producers, 2023-2029

date 22 Apr 2023

date Medical Care

The global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 26 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

attention deficit hyperactivity disorder adhd therapeutics

Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>